Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials

被引:142
作者
Hotta, K
Matsuo, K
Ueoka, H
Kiura, K
Tabata, M
Tanimoto, M
机构
[1] Okayama Univ, Sch Med, Dept Med 2, Okayama 7008558, Japan
[2] Aichi Canc Ctr, Res Inst, Dept Epidemiol & Prevent, Nagoya, Aichi, Japan
关键词
D O I
10.1200/JCO.2004.01.153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer (NSCLC) remains to be defined. This study was aimed at re-evaluating the effectiveness of adjuvant chemotherapy in patients with resected NSCLC, by performing a meta-analysis of relevant trials. Methods We performed a literature search to identify trials reported after the publication of a meta-analysis in 1995, comparing patients with NSCLC receiving chemotherapy after surgery with those undergoing surgery alone. The hazard ratio (HR) was estimated to assess the survival advantage of adjuvant chemotherapy. Results Eleven trials conducted on a total of 5,716 patients were identified by the literature Search. In these trials, hazard ratio estimates suggested that adjuvant chemotherapy yielded a survival advantage over surgery alone (HR, 0.872; 95% Cl, 0.805 to 0.944; P = .001). In a subset analysis, both cisplatin-based chemotherapy (HR, 0.891; 95% Cl, 0.815 to 0.975; P = .012) and single-agent therapy with tegafur and uracil (UFT; HR, 0.799; 95% Cl, 0.668 to 0.957; P = .015) were found to yield a significant survival benefit. The toxicities of adjuvant chemotherapy were found to be generally mild. Conclusion This is the first updated meta-analysis demonstrating the importance of cisplatin-based chemotherapy and single-agent UFT therapy as adjuvant chemotherapy in the treatment of resected NSCLC. Although the results must be carefully interpreted because of one limitation (the meta-analysis was performed with abstracted data), they raise critical issues that must be resolved in future studies. (C) 2004 by American Society of Clinical Oncology.
引用
收藏
页码:3860 / 3867
页数:8
相关论文
共 50 条
[11]   The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials [J].
Tian, Rong-Hua ;
Wu, Xia ;
Liu, Xia ;
Yang, Jin-Wang ;
Ji, Hua-Liang ;
Yan, Yong-Jin .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) :571-575
[12]   Adjuvant chemotherapy for completely resected non-small-cell lung cancer. [J].
Greco, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09) :689-689
[13]   Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Al Feghali, Karine A. ;
Ballout, Rami A. ;
Khamis, Assem M. ;
Akl, Elie A. ;
Geara, Fady B. .
FRONTIERS IN ONCOLOGY, 2018, 8
[14]   Concurrent vs sequential chemoradiotherapy for patients with advanced non-small-cell lung cancer A meta-analysis of randomized controlled trials [J].
Xiao, Wei ;
Hong, Mei .
MEDICINE, 2021, 100 (11) :E21455
[15]   Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: Meta-analysis of randomized clinical trials [J].
Bria, Emilio ;
Gralla, Richard J. ;
Raftopoulos, Harry ;
Cuppone, Federica ;
Milella, Michele ;
Sperduti, Isabella ;
Carlini, Paolo ;
Terzoli, Edmondo ;
Cognetti, Francesco ;
Giannarelli, Diana .
LUNG CANCER, 2009, 63 (01) :50-57
[16]   Effect of postoperative adjuvant chemotherapy with UFT on survival in patients with clinical stage IA non-small-cell lung cancer: an exploratory analysis from a meta-analysis of 6 randomized controlled trials [J].
Tsuboi, M. ;
Hamada, C. ;
Ohta, M. ;
Fujimura, S. ;
Kodama, K. ;
Imaizumi, M. ;
Wada, H. .
EJC SUPPLEMENTS, 2009, 7 (02) :510-510
[17]   Role for adjuvant chemotherapy in patients with resected small cell lung cancer [J].
Du, Lingling ;
Waqar, Saiama N. ;
Morgensztern, Daniel .
JOURNAL OF THORACIC DISEASE, 2016, 8 (08) :1891-1892
[18]   Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials [J].
Bria, Emilio ;
Cuppone, Federica ;
Ciccarese, Mariangela ;
Nistio, Cecilia ;
Facciolo, Francesco ;
Milella, Michele ;
Izzo, Fiorentino ;
Terzoli, Edmondo ;
Cognetti, Francesco ;
Giannarelli, Diana .
CANCER TREATMENT REVIEWS, 2006, 32 (08) :583-587
[19]   The Safety and Effectiveness of Bevacizumab in the Treatment of Nonsquamous Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials [J].
Zhou, Yue ;
He, Mei ;
Li, Rui ;
Peng, Yuan ;
Li, Feng ;
Li, Shengqian ;
Yang, Ming .
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[20]   Strengths and Weaknesses of Immunotherapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of 12 Randomized Controlled Trials [J].
Wang, Juan ;
Zou, Ze-Hong ;
Xia, Hong-Lin ;
He, Jian-Xing ;
Zhong, Nan-Shan ;
Tao, Ai-Lin .
PLOS ONE, 2012, 7 (03)